Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.

Shakiba, Maryam; Nazemipour, Maryam; Salari, Arsalan; Mehrabian, Fardin; Nazari, Seyed Saeed H; Rezvani, Seyed Mahmoud; Ghasempour, Zahra; Heidarzadeh, Abtin; Mansournia, Mohammad Ali

Shakiba, Maryam; Nazemipour, Maryam; Salari, Arsalan; Mehrabian, Fardin; Nazari, Seyed Saeed H; Rezvani, Seyed Mahmoud; Ghasempour, Zahra; Heidarzadeh, Abtin; Mansournia, Mohammad Ali.

Emerg Infect Dis ; 27(2): 636-638, 2021 02.

Article in English | MEDLINE | ID: covidwho-993266

ABSTRACT

ABSTRACT

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).

Subject(s)

Antibodies, Viral/blood; COVID-19 Serological Testing/statistics & numerical data; COVID-19/epidemiology; SARS-CoV-2/immunology; Antibodies, Viral/immunology; COVID-19/blood; COVID-19/immunology; Cross-Sectional Studies; Family Characteristics; Female; Humans; Iran/epidemiology; Male; Seroepidemiologic Studies

Keywords

COVID-19; Guilan; Iran; SARS-CoV-2; asymptomatic infections; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Emerg Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google